Literature DB >> 7730681

Left ventricular opacification after intravenous injection of Albunex. The effect of different administration procedures.

H S Sonne1, P D Christensen, B Muan, J Assentoft, T Haider, B O Kristensen.   

Abstract

A clinical study has been performed to investigate the influence of different administration procedures on the degree of contrast enhancement of the left ventricle. The administration variables assessed included Albunex injection rate, arm position, flushing rate and flushing fluid. Twenty-four healthy male volunteers were included. Compared to an injection rate of 1 ml/sec an injection rate of Albunex of 2 ml/sec caused an earlier appearance of contrast in the right ventricle (1 heart beat), whereas transpulmonary passage was not influenced. Horizontal arm position caused a delay in time to peak intensity of 2 to 3 heart beats in both systole and diastole as compared to elevated arm position. Injection rate of 1 ml/sec compared to 2 ml/sec caused a higher peak intensity and mean area under the curve and a longer mean time to peak intensity and transit time. Differences varied from 6 to 230 grey level units out of mean values of 2500. All the observed differences were small and thus probably of no clinical importance. The present study indicates that improvements in the pressure stability characteristics of the albumin microspheres in Albunex have been achieved. This implies that a simple administration procedure can be used. It is recommended that the contrast agent, after resuspension, is injected through a three-way stop cock cannula, followed by 10 ml of saline for flushing. The cannulas or syringes used should be no smaller than 20 G. The injection rate should be 1-2 ml/sec, depending on the diameter of the cannula. By using this procedure, a reliable transpulmonary passage and left ventricular opacification may be obtained.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730681     DOI: 10.1007/bf01148953

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  9 in total

1.  Intravenous contrast echocardiography with use of sonicated albumin in humans: systolic disappearance of left ventricular contrast after transpulmonary transmission.

Authors:  J R Shapiro; S A Reisner; G S Lichtenberg; R S Meltzer
Journal:  J Am Coll Cardiol       Date:  1990-12       Impact factor: 24.094

2.  Clinical experience with Albunex: a standard echocontrast agent for intravenous and intracoronary use.

Authors:  F J Cate; J H Cornel; P Widimsky; W Vletter; P Serruys; A Waaler
Journal:  Am J Card Imaging       Date:  1991-09

3.  Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results.

Authors:  S B Feinstein; J Cheirif; F J Ten Cate; P R Silverman; P A Heidenreich; C Dick; R M Desir; W F Armstrong; M A Quinones; P M Shah
Journal:  J Am Coll Cardiol       Date:  1990-08       Impact factor: 24.094

4.  Echocardiography of the aortic root.

Authors:  R Gramiak; P M Shah
Journal:  Invest Radiol       Date:  1968 Sep-Oct       Impact factor: 6.016

5.  Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin.

Authors:  C Christiansen; H Kryvi; P C Sontum; T Skotland
Journal:  Biotechnol Appl Biochem       Date:  1994-06       Impact factor: 2.431

6.  Sonicated serum albumin in contrast echocardiography: improved segmental wall motion depiction and implications for stress echocardiography.

Authors:  L J Crouse
Journal:  Am J Cardiol       Date:  1992-06-18       Impact factor: 2.778

7.  Biochemical characterization of air-filled albumin microspheres.

Authors:  H Hellebust; C Christiansen; T Skotland
Journal:  Biotechnol Appl Biochem       Date:  1993-12       Impact factor: 2.431

8.  Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation.

Authors:  M W Keller; S B Feinstein; D D Watson
Journal:  Am Heart J       Date:  1987-09       Impact factor: 4.749

9.  Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres.

Authors:  W E Sanders; J Cheirif; R Desir; W A Zoghbi; B D Hoyt; P E Schulz; M A Quiñones
Journal:  Am Heart J       Date:  1991-12       Impact factor: 4.749

  9 in total
  4 in total

Review 1.  Section 8--clinical relevance. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 2.  Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 3.  Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

Review 4.  Section 4--bioeffects in tissues with gas bodies. American Institute of Ultrasound in Medicine.

Authors: 
Journal:  J Ultrasound Med       Date:  2000-02       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.